{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T15:45:31Z","timestamp":1758815131310},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"S5","license":[{"start":{"date-parts":[[1990,9,1]],"date-time":"1990-09-01T00:00:00Z","timestamp":652147200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drug Ther"],"published-print":{"date-parts":[[1990,9]]},"DOI":"10.1007\/bf02018296","type":"journal-article","created":{"date-parts":[[2005,8,12]],"date-time":"2005-08-12T02:33:18Z","timestamp":1123813998000},"page":"935-940","source":"Crossref","is-referenced-by-count":12,"title":["Use of nifedipine in hypertension and Raynaud's phenomenon"],"prefix":"10.1007","volume":"4","author":[{"given":"W.","family":"Kiowski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Erne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. R.","family":"B\u00fchler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02018296_CR1","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1152\/physrev.1979.59.3.606","volume":"59","author":"TB Bolton","year":"1979","unstructured":"Bolton TB. Mechanisms of action of transmitters and other substances on smooth muscle.Physiol Rev. 1979;59:606\u2013618.","journal-title":"Physiol Rev."},{"key":"BF02018296_CR2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1146\/annurev.pa.17.040177.001053","volume":"17","author":"A Fleckenstein","year":"1977","unstructured":"Fleckenstein A. Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle.Ann Rev Pharmacol Toxicol 1977;17:149\u2013166.","journal-title":"Ann Rev Pharmacol Toxicol"},{"key":"BF02018296_CR3","doi-asserted-by":"crossref","first-page":"343s","DOI":"10.1042\/cs059343s","volume":"59","author":"P Lund-Johanson","year":"1980","unstructured":"Lund-Johanson P. State of the art review: Hemodynamics in essential hypertension.Clin Sci 59:343s-354s, 1980.","journal-title":"Clin Sci"},{"key":"BF02018296_CR4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0033-0620(75)90002-X","volume":"18","author":"JD Coffman","year":"1975","unstructured":"Coffman JD, Davies WT. Vasospastic diseases: A review.Prog Cardiovasc Dis 1975:18:123\u2013146.","journal-title":"Prog Cardiovasc Dis"},{"key":"BF02018296_CR5","first-page":"II26","volume":"4","author":"UL Hulthen","year":"1982","unstructured":"Hulthen UL, Bolli P, Amann FW, et al. Enhanced vasodilatation in essential hypertension by calcium channel blockade with verapamil.Hypertension 1982;4:II26-II31.","journal-title":"Hypertension"},{"key":"BF02018296_CR6","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1042\/cs0630033","volume":"63","author":"BF Robinson","year":"1982","unstructured":"Robinson BF, Dobbs RG, Bayley S. Effects of forearm resistance vessels to verapamil and sodium nitroprusside in normotensive and hypertensive man.Clin Sci 1982;63:33\u201342.","journal-title":"Clin Sci"},{"key":"BF02018296_CR7","doi-asserted-by":"crossref","first-page":"I70","DOI":"10.1161\/01.HYP.5.2_Pt_2.I70","volume":"5","author":"W Kiowski","year":"1983","unstructured":"Kiowski W, Bertel O, Erne P et al. Hemodynamic and reflex mechanism of acute and chronic antihypertensive therapy with the calcium channel blocker nifedipine.Hypertension 1983:5:I70-I74.","journal-title":"Hypertension"},{"issue":"Suppl 1","key":"BF02018296_CR8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00005344-198900131-00006","volume":"13","author":"W Kiowski","year":"1989","unstructured":"Kiowski W, Linder L, B\u00fchler FR, Experimental and clinical exprience with the calcium antagonist diltiazem in hypertension.J Cardiovasc Pharmacol 1989;13(Suppl 1):25\u201328.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"Suppl 4","key":"BF02018296_CR9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/00005344-198700094-00004","volume":"9","author":"BP Bean","year":"1987","unstructured":"Bean BP, Sturek M, Puga A, Hermsmyer K. Nitredipine block of calcium channels in cardiac and vacular muscle.J Cardiovasc Pharmacol 1987:9 (Suppl 4):17\u201324.","journal-title":"J Cardiovasc Pharmacol"},{"key":"BF02018296_CR10","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1085\/jgp.69.4.497","volume":"69","author":"B Hille","year":"1977","unstructured":"Hille B, Local anaesthetics. Hydrophilic and hydrophobic pathways for the drug:receptor interaction.J Gen Physiol 1977:69:497\u2013515.","journal-title":"J Gen Physiol"},{"key":"BF02018296_CR11","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1136\/bmj.281.6253.1462","volume":"281","author":"LH Opie","year":"1980","unstructured":"Opie LH, White DA. Adverse reaction between nifedipine and beta blockade.Br Med J 1980:281:1462.","journal-title":"Br Med J"},{"key":"BF02018296_CR12","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1001\/archinte.1974.00320180135012","volume":"133","author":"J Koch-Weser","year":"1974","unstructured":"Koch-Weser J. Vasodilating drugss in the treatment of hypertension.Arch Intern Med 1974:133:1017\u20131027.","journal-title":"Arch Intern Med"},{"key":"BF02018296_CR13","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1161\/01.HYP.5.2_Pt_2.I70","volume":"5","author":"W Kiowski","year":"1983","unstructured":"Kiowski W, Bertel O, Erne P et al. Hemodynamic and reflex mechanism of acute and chronic antihypertensive therapy with the calcium channel blocker nifedipine.Hypertension 1983:5:170\u2013174.","journal-title":"Hypertension"},{"key":"BF02018296_CR14","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S0735-1097(86)80503-4","volume":"7","author":"W Kiowski","year":"1986","unstructured":"Kiowski W, Erne P, Bolli P, B\u00fchler FR. Sympathetic reflex activation and antihypertensive response to nifedipine.J Am coll Cardiol 1986:7:344\u2013348.","journal-title":"J Am coll Cardiol"},{"key":"BF02018296_CR15","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1161\/01.CIR.59.5.1056","volume":"59","author":"MT Olivari","year":"1979","unstructured":"Olivari MT, Bartorelli C, Polese A, et al. Treatment of hypertension with nifedipine, a calcium antagonistic agent.Circulation 1979:59:1056\u20131062.","journal-title":"Circulation"},{"issue":"Suppl 3","key":"BF02018296_CR16","first-page":"369","volume":"4","author":"GA Gould","year":"1982","unstructured":"Gould GA, Mann S, Kieso H, et al. Slow channel inhibitors verapamil and nifedipine in the management of hypertension.J Cardiovasc Pharmacol 1982:4(Suppl 3):369\u2013373.","journal-title":"J Cardiovasc Pharmacol"},{"key":"BF02018296_CR17","unstructured":"Magometshnigg D. Zur Therapie bie hypertonen Krisen.Dtsch Med Wschr 1979:1423\u20131426."},{"key":"BF02018296_CR18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1136\/bmj.286.6358.19","volume":"286","author":"O Bertel","year":"1983","unstructured":"Bertel O, Conen D, Rad\u00fc EW et al. Nifedipine in hypertensive emergencies.Br Med J 1983:286:19\u201320.","journal-title":"Br Med J"},{"key":"BF02018296_CR19","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1161\/01.CIR.61.5.913","volume":"61","author":"MD Guazzi","year":"1980","unstructured":"Guazzi MD, Fiorentini C, Olivari MT et al. Short and longterm efficacy of a calcium-antagonistic agent (nifedipine) combined with methyldopa in the treatment of severe hypertension.Circulation 1980:61:913\u2013919.","journal-title":"Circulation"},{"key":"BF02018296_CR20","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1161\/01.CIR.70.2.279","volume":"70","author":"MD Guazi","year":"1984","unstructured":"Guazi MD, De Cesare N, Galli C, et al. Calcium-channel blockade with nifedipine and angiotensin converting enzyme inhibition with captopril in the therapy of patients with severe primary hypertension.Circulation 1984:70:279\u2013284.","journal-title":"Circulation"},{"issue":"Suppl 4","key":"BF02018296_CR21","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/00005344-198507001-00017","volume":"7","author":"RML Brouwer","year":"1985","unstructured":"Brouwer RML, Bolli P, Erne P et al. Antihypertensive treatement using calcium antagonists in combination with captopril rather than diuretics.J Cardiovasc Pharmacol 1985;7(Suppl 4):88\u201391.","journal-title":"J Cardiovasc Pharmacol"},{"key":"BF02018296_CR22","first-page":"85","volume":"33","author":"J Heslop","year":"1983","unstructured":"Heslop J, Coggan D, Acheson ED. The prevalence of intermitten digital ischemia (Raynaud's phenomenon) in a general pratice.J R Coll Tract 1983:33:85\u201389.","journal-title":"J R Coll Tract"},{"key":"BF02018296_CR23","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0002-9149(82)90521-5","volume":"49","author":"JA Hill","year":"1982","unstructured":"Hill JA, Feldman RL, Pepine CI, Conti CR. Randomized double-blind comparison of nifedipine and isosorbide dinitrate in patients with coronary arterial spasm.Am j Cardiol 1982;49:431\u2013438.","journal-title":"Am j Cardiol"},{"key":"BF02018296_CR24","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S0140-6736(82)91508-2","volume":"2","author":"CD Smith","year":"1982","unstructured":"Smith CD, McKendry RJR, Controlled trial of nifedipine in the treatment of Raynaud's phenomenon.Lancet 1982:2:1299\u20131301.","journal-title":"Lancet"},{"key":"BF02018296_CR25","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1056\/NEJM198304143081507","volume":"308","author":"RJ Rodeheffer","year":"1983","unstructured":"Rodeheffer RJ, Rommer JA, Wigley F, Smith CR. Controlled double-blind trial of nifedipine in the treatment of Raynaud's phenomenon.N Engl J Med 1983;308:880\u2013883.","journal-title":"N Engl J Med"},{"key":"BF02018296_CR26","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/oxfordjournals.eurheartj.a062040","volume":"7","author":"DOC Corbin","year":"1986","unstructured":"Corbin DOC, Wood DA, Mactintyre CCA, Housley E. A randomized double blind cross-over trial of nifedipine in the treatment of primary Raynaud's phenomenon.Eur Heart J 1986:7:165\u2013170.","journal-title":"Eur Heart J"},{"key":"BF02018296_CR27","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/0002-8703(84)90627-6","volume":"108","author":"MA Creager","year":"1984","unstructured":"Creager MA, Pariser KM, Winston EM et al. Nifedipine induced fingertip vasodilation in patients with Raynaud's phenomenon.Am Heart J 1984:108:370\u2013373.","journal-title":"Am Heart J"},{"key":"BF02018296_CR28","doi-asserted-by":"crossref","unstructured":"Roath S, Management of Raynaud's phenomenon. Focus on newer treatment.Drugs 1989:700\u2013712.","DOI":"10.2165\/00003495-198937050-00005"},{"key":"BF02018296_CR29","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.0954-6820.1984.tb04983.x","volume":"215","author":"H Nilsson","year":"1984","unstructured":"Nilsson H, Jonasson T, Ringqvist I. Treatment of digital vasospastic disease with the calcium entry blocker nifedipine.Acta Med Scand 1984:215:135\u2013139.","journal-title":"Acta Med Scand"},{"issue":"Suppl C","key":"BF02018296_CR30","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/eurheartj\/4.suppl_C.123","volume":"4","author":"A Kahan","year":"1983","unstructured":"Kahan A, Weber S, Amor B, et al. Calcium entry blocking agents in digital vasospasm (Raynaud's phenomonon).Eur Heart J 1983:4 (Suppl C):123\u2013129.","journal-title":"Eur Heart J"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02018296.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02018296\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02018296","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T11:45:52Z","timestamp":1557834352000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02018296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,9]]},"references-count":30,"journal-issue":{"issue":"S5","published-print":{"date-parts":[[1990,9]]}},"alternative-id":["BF02018296"],"URL":"https:\/\/doi.org\/10.1007\/bf02018296","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,9]]}}}